Alytesin (CAS 31078-12-3)

Alytesin, a peptide isolated from the skin of the midwife toad (Alytes obstetricans), has garnered significant interest in scientific research, particularly in the field of neuroscience and peptide pharmacology. This compound acts as an agonist for bombesin-like receptors (BLRs), specifically targeting the gastrin-releasing peptide receptor (GRPR) subtype. Upon binding to GRPR, alytesin triggers a cascade of intracellular signaling events, including activation of phospholipase C (PLC), protein kinase C (PKC), and inositol trisphosphate (IP3) production. These signaling pathways ultimately lead to the modulation of neurotransmitter release, neuronal excitability, and synaptic plasticity. Research utilizing alytesin has provided valuable insights into the physiological roles of GRPR activation in various regions of the central nervous system, including the modulation of pain perception, stress responses, and feeding behavior. Additionally, alytesin and its analogs have been employed as pharmacological tools for investigating the functional significance of GRPR signaling in animal models of neurological disorders, such as anxiety, depression, and addiction. Its specificity for GRPR and its ability to modulate neuronal activity make alytesin a valuable asset for unraveling the complexities of neuropeptide signaling and its implications in brain function and behavior.